PDCD1 and neoplasm: The cell surface receptor PD-1 is expressed by T cells when activated during priming or expansion and binds to one of two ligands: programmed cell death ligand 1 (PD-L1) and PD-L2, which are produced by normal and tumor cells in response to cytokines (such as interferon-γ).